אנדרוקור 50
bayer israel ltd - cyproterone acetate - טבליה - cyproterone acetate 50 mg - cyproterone - cyproterone - for antiandrogen therapy in men: sexual disorders, inoperable prostatic carcinoma.
אנדרוקור 50
bayer israel ltd - cyproterone acetate - טבליה - cyproterone acetate 50 mg - cyproterone - cyproterone - for antiandrogen therapy in men: sexual disorders, inoperable prostatic carcinoma.
אנדרוקור 10
bayer israel ltd - cyproterone acetate - טבליה - cyproterone acetate 10 mg - cyproterone - cyproterone - anti androgen for moderate and severe signs of androgenization in the women.
דיאנה 35
bayer israel ltd - cyproterone acetate; ethinylestradiol - טבליה - ethinylestradiol 35 mcg; cyproterone acetate 2 mg - cyproterone and estrogen - cyproterone and estrogen - treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age. for the treatment of acne, diane-35 should only be used after topical therapy or systemic antibiotic treatments have failed.
דיאנה 35
bayer israel ltd - cyproterone acetate; ethinylestradiol - טבליה - ethinylestradiol 35 mcg; cyproterone acetate 2 mg - cyproterone and estrogen - cyproterone and estrogen - treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age. for the treatment of acne, diane-35 should only be used after topical therapy or systemic antibiotic treatments have failed.
אנדרוקור 50
bayer israel ltd - cyproterone acetate - טבליה - cyproterone acetate 50 mg - cyproterone
אסטל 35
taro international ltd, israel - cyproterone acetate; ethinylestradiol - טבליה - ethinylestradiol 0.035 mg; cyproterone acetate 2 mg - for the treatment of signs of androgenization in women such as pronounced forms of acne, androgenic alopecia and mild forms of hirsutism.
אסטל 35 טבליות
taro international ltd, israel - cyproterone acetate; ethinylestradiol - טבליה - ethinylestradiol 0.035 mg; cyproterone acetate 2 mg
קופקסון 20 מגמל
teva israel ltd - glatiramer acetate - תמיסה להזרקה - glatiramer acetate 20 mg/ml - glatiramer acetate - glatiramer acetate - for reducing the frequency of relapses in pateints with relapsing-remitting multiple sclerosis. copaxone is indicated for the treatment of patients who have experienced a well defined first clinical episode and are determined to be at high risk of developing clinically definite multiple sclerosis (cdms). these patients should have mri findings which are compatible with the diagnosis of multiple sclerosis.
קופקסון 20 מגמל
teva pharmaceutical industries ltd, israel - glatiramer acetate - תמיסה להזרקה - glatiramer acetate 20 mg/dose - glatiramer acetate - glatiramer acetate - for reducing the frequency of relapses in pateints with relapsing-remitting multiple sclerosis. copaxone is indicated for the treatment of patients who have experienced a well defined first clinical episode and are determined to be at high risk of developing clinically definite multiple sclerosis (cdms). these patients should have mri findings which are compatible with the diagnosis of multiple sclerosis.